Literature DB >> 30298592

The comparison of an acellular matrix graft with an autologous venous graft in the surgical treatment of Peyronie's disease.

Onder Kayigil1, Muhammet Fuat Ozcan2, Ozer Ural Cakici2.   

Abstract

The aim of this study was to evaluate acellular porcine pericardium (APP) and compared the results with those obtained from venous grafts in the surgical management of Peyronie's disease (PD). An APP (Group 1) and an autologous saphenous vein graft (Group 2) were used in 27 and 26 patients, respectively for Peyronie's correction. The patients' age, body mass index (BMI), operation time, duration of follow-up, preoperative and postoperative IIEF-5 scores, plaque size and loss of sensation were evaluated in both groups. There were no differences between the two groups in terms of age, BMI, follow-up period, and preoperative and postoperative IIEF-5 scores. The postoperative IIEF-5 scores were higher than the preoperative IIEF-5 scores in both groups. The operation time was significantly longer in Group 2 than in Group 1. The duration of sensation loss was shorter in Group 1 compared to Group 2. Penile shortening was similar in both groups.
© 2018 Blackwell Verlag GmbH.

Entities:  

Keywords:  Peyronie's disease; grafting material; surgery

Mesh:

Year:  2018        PMID: 30298592     DOI: 10.1111/and.13168

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  2 in total

Review 1.  Modern treatment strategies for penile prosthetics in Peyronie's disease: a contemporary clinical review.

Authors:  Matthew J Ziegelmann; M Ryan Farrell; Laurence A Levine
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

2.  Saphenous Vein Graft for Treatment of Peyronie's Disease, a Comparison between Single and Multiple Graft Reconstruction.

Authors:  Kamyar Tavakoli Tabassi; Mahdi Mottaghi; Negar Nekooei; Sanaz Salehi; Atena Aghaee; Salman Soltani
Journal:  World J Plast Surg       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.